These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

917 related articles for article (PubMed ID: 32662525)

  • 1. Clinical, radiological, and laboratory characteristics and risk factors for severity and mortality of 289 hospitalized COVID-19 patients.
    Zhang JJ; Cao YY; Tan G; Dong X; Wang BC; Lin J; Yan YQ; Liu GH; Akdis M; Akdis CA; Gao YD
    Allergy; 2021 Feb; 76(2):533-550. PubMed ID: 32662525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive role of clinical features in patients with coronavirus disease 2019 for severe disease.
    Mo J; Liu J; Wu S; LÜ A; Xiao L; Chen D; Zhou Y; Liang L; Liu X; Zhao J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2020 May; 45(5):536-541. PubMed ID: 32879103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis.
    Malik P; Patel U; Mehta D; Patel N; Kelkar R; Akrmah M; Gabrilove JL; Sacks H
    BMJ Evid Based Med; 2021 Jun; 26(3):107-108. PubMed ID: 32934000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.
    Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD
    Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
    Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the correlates of lymphopenia and independent predictors of poor clinical outcome in adults hospitalized with COVID-19 in Australia.
    Hastak P; Cromer D; Malycha J; Andersen CR; Raith E; Davenport MP; Plummer M; Sasson SC
    Sci Rep; 2024 May; 14(1):11102. PubMed ID: 38750134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory biomarker predictors for disease progression and outcome among Egyptian COVID-19 patients.
    Fathalla LA; Kamal LM; Salaheldin O; Khalil MA; Kamel MM; Fahim HH; Abdel-Moneim YA; Abdulhakim JA; Abdel-Moneim AS; El-Meligui YM
    Int J Immunopathol Pharmacol; 2022; 36():3946320221096207. PubMed ID: 35622504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Mortality of COVID-19 Patient Based on Clinical Course: A Single Center Retrospective Case-Control Study.
    Zhang J; Wang Z; Wang X; Hu Z; Yang C; Lei P
    Front Immunol; 2021; 12():581469. PubMed ID: 33664741
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics, laboratory abnormalities and CT findings of COVID-19 patients and risk factors of severe disease: a systematic review and meta-analysis.
    Xie J; Wang Q; Xu Y; Zhang T; Chen L; Zuo X; Liu J; Huang L; Zhan P; Lv T; Song Y
    Ann Palliat Med; 2021 Feb; 10(2):1928-1949. PubMed ID: 33548996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with death outcome in patients with severe coronavirus disease-19 (COVID-19): a case-control study.
    Pan F; Yang L; Li Y; Liang B; Li L; Ye T; Li L; Liu D; Gui S; Hu Y; Zheng C
    Int J Med Sci; 2020; 17(9):1281-1292. PubMed ID: 32547323
    [No Abstract]   [Full Text] [Related]  

  • 11. A meta-analysis of SARS-CoV-2 patients identifies the combinatorial significance of D-dimer, C-reactive protein, lymphocyte, and neutrophil values as a predictor of disease severity.
    Singh K; Mittal S; Gollapudi S; Butzmann A; Kumar J; Ohgami RS
    Int J Lab Hematol; 2021 Apr; 43(2):324-328. PubMed ID: 33010111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and laboratory characteristics of 215 cases of coronavirus disease 2019 with different prognosis].
    Zhu M; Zhu Y; Guo F; Zhang J; Liu W; Hou W
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Dec; 32(12):1428-1433. PubMed ID: 33541492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical characteristics of Egyptian male patients with COVID-19 acute respiratory distress syndrome.
    Doghish AS; Elkhatib WF; Hassan EA; Elkhateeb AF; Mahmoud EE; Ahmed MI; Khalil MAF
    PLoS One; 2021; 16(4):e0249346. PubMed ID: 33861750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of clinical parameters in predicting the severity of COVID-19.
    Shang W; Dong J; Ren Y; Tian M; Li W; Hu J; Li Y
    J Med Virol; 2020 Oct; 92(10):2188-2192. PubMed ID: 32436996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactate-dehydrogenase associated with mortality in hospitalized patients with COVID-19 in Mexico: a multi-centre retrospective cohort study.
    Vidal-Cevallos P; Higuera-De-La-Tijera F; Chávez-Tapia NC; Sanchez-Giron F; Cerda-Reyes E; Rosales-Salyano VH; Servin-Caamaño A; Vázquez-Medina MU; Méndez-Sánchez N
    Ann Hepatol; 2021; 24():100338. PubMed ID: 33647501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors affecting mortality in geriatric patients hospitalized with COVID-19.
    Bağ Soytaş R; Ünal D; Arman P; Suzan V; Emiroğlu Gedik T; Can G; Korkmazer B; Karaali R; Börekçi Ş; Kuşkucu MA; Yavuzer H; Suna Erdinçler D; Döventaş A
    Turk J Med Sci; 2021 Apr; 51(2):454-463. PubMed ID: 33315348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laboratory features of severe vs. non-severe COVID-19 patients in Asian populations: a systematic review and meta-analysis.
    Ghahramani S; Tabrizi R; Lankarani KB; Kashani SMA; Rezaei S; Zeidi N; Akbari M; Heydari ST; Akbari H; Nowrouzi-Sohrabi P; Ahmadizar F
    Eur J Med Res; 2020 Aug; 25(1):30. PubMed ID: 32746929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China.
    Hu X; Hu C; Yang Y; Chen J; Zhong P; Wen Y; Chen X
    Ther Adv Respir Dis; 2020; 14():1753466620963035. PubMed ID: 33138694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
    Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
    Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy assessment of allogeneic human dental pulp stem cells to treat patients with severe COVID-19: structured summary of a study protocol for a randomized controlled trial (Phase I / II).
    Ye Q; Wang H; Xia X; Zhou C; Liu Z; Xia ZE; Zhang Z; Zhao Y; Yehenala J; Wang S; Zhou G; Hu K; Wu B; Wu CT; Wang S; He Y
    Trials; 2020 Jun; 21(1):520. PubMed ID: 32532356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.